Discover
MNPR
Monopar Therapeutics Inc.
95.03
2 x 95.95
1 x 96.95
bid
ask
+
2.44
2.64%
2 @ 04:00 PM
95.03 +0.00 (0.00%)
| Ytd | 45.53% | |
| 1y | 183.16% |
93.75
day range
100.33
29.18
52 week range
105.00
| Open | 93.83 | Prev Close | 92.59 | Low | 93.75 | High | 100.33 | Mkt Cap | 636.61M |
| Vol | 176.91K | Avg Vol | 171.61K | EPS | -1.93 | P/E | N/A | Forward P/E | -10.17 |
| Beta | 1.10 | Short Ratio | 0.15 | Inst. Own | 24.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 64.05 | 200-d Avg | 68.35 | 1yr Est | 27.33 |
| Income Statement | |||
| Operating Expenses | 5.23M | ||
| Research and Development Expense | 3.49M | ||
| Selling, General and Administrative Expense | 1.74M | ||
| Operating Income | -5.23M | ||
| Net Income | -3.89M | ||
| Net Income Common Stock | -3.89M | ||
| Net Income Common Stock (USD) | -3.89M | ||
| Consolidated Income | -3.89M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | -3.89M | ||
| Earning Before Interest & Taxes (USD) | -3.89M | ||
| Weighted Average Shares | 8.54M | ||
| Weighted Average Shares Diluted | 8.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 52.54M | ||
| Cash and Equivalents (USD) | 52.54M | ||
| Investments | 84.95M | ||
| Investments Current | 84.95M | ||
| Current Assets | 137.74M | ||
| Property, Plant & Equipment Net | 239.88K | ||
| Total Assets | 137.98M | ||
| Total Debt | 131.57K | ||
| Current Liabilities | 2.46M | ||
| Debt Non-Current | 131.57K | ||
| Total Liabilities | 2.59M | ||
| Accumulated Retained Earnings (Deficit) | -93.40M | ||
| Accumulated Other Comprehensive Income | 98.52K | ||
| Shareholders Equity | 135.39M | ||
| Shareholders Equity (USD) | 135.39M | ||
| Assets Non-Current | 239.88K | ||
| Total Debt (USD) | 131.57K | ||
| Liabilities Non-Current | 131.57K | ||
| Trade and Non-Trade Payables | 2.46M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -200.20K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.29M | ||
| Net Cash Flow from Investing | -5.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -5.58M | ||
| Net Cash Flow from Operations | -3.47M | ||
| Effect of Exchange Rate Changes on Cash | -31.63K | ||
| Share Based Compensation | 1.69M | ||